SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses:
SEC Accession No. 0001104659-21-008864
Filing Date
2021-01-28
Accepted
2021-01-28 17:18:47
Documents
2

Document Format Files

Seq Description Document Type Size
1 FREE WRITING PROSPECTUS tm214558d1_fwp.htm FWP 12417
2 GRAPHIC image_001.jpg GRAPHIC 4071
  Complete submission text file 0001104659-21-008864.txt   19906
Mailing Address 4260 U.S. ROUTE 1 MONMOUTH JUNCTION NJ 08852
Business Address 4260 U.S. ROUTE 1 MONMOUTH JUNCTION NJ 08852 6096193990
Outlook Therapeutics, Inc. (Filed by) CIK: 0001649989 (see all company filings)

IRS No.: 383982704 | State of Incorp.: DE | Fiscal Year End: 0930
Type: FWP
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 4260 U.S. ROUTE 1 MONMOUTH JUNCTION NJ 08852
Business Address 4260 U.S. ROUTE 1 MONMOUTH JUNCTION NJ 08852 6096193990
Outlook Therapeutics, Inc. (Subject) CIK: 0001649989 (see all company filings)

IRS No.: 383982704 | State of Incorp.: DE | Fiscal Year End: 0930
Type: FWP | Act: 34 | File No.: 333-231922 | Film No.: 21566392
SIC: 2836 Biological Products, (No Diagnostic Substances)